Beth C Seidenberg insider trades
Open-market stock purchases and sales by Beth C Seidenberg, Unknown at Latigo Biotherapeutics, Inc, from SEC Form 4 filings since May 13, 2010.
Track record: 20% of 5 scored buys are up 5% or more since purchase, averaging -23%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Aug 10, 2026 | LTGO Latigo Biotherapeutics, Inc | Bought (not open market) | — |
| Aug 10, 2026 | LTGO Latigo Biotherapeutics, Inc | Bought (not open market) | — |
| Aug 10, 2026 | LTGO Latigo Biotherapeutics, Inc | Bought (not open market) | — |
| Aug 10, 2026 | LTGO Latigo Biotherapeutics, Inc | Bought (not open market) | — |
| Aug 10, 2026 | LTGO Latigo Biotherapeutics, Inc | Bought (not open market) | — |
| Aug 10, 2026 | LTGO Latigo Biotherapeutics, Inc | Bought (not open market) | — |
| Aug 10, 2026 | LTGO Latigo Biotherapeutics, Inc | Bought (not open market) | — |
| Jun 12, 2026 | SGMT Sagimet Biosciences Inc | Bought (not open market) | — |
| May 27, 2026 | KYTX Kyverna Therapeutics, Inc | Bought (not open market) | — |
| May 27, 2026 | KYTX Kyverna Therapeutics, Inc | Bought (not open market) | — |
| May 21, 2026 | VERA Vera Therapeutics, Inc | Bought (not open market) | — |
| Dec 18, 2025 | KYTX Kyverna Therapeutics, Inc | Bought | $1M |
Companies traded
- LTGO Latigo Biotherapeutics, Inc: other filings, last Aug 10, 2026
- SGMT Sagimet Biosciences Inc: 1 buy, last Jun 12, 2026
- KYTX Kyverna Therapeutics, Inc: 1 buy, last May 27, 2026
- VERA Vera Therapeutics, Inc: 19 buys, 5 sales, last May 21, 2026
- SLRN ACELYRIN, Inc: 2 buys, last May 21, 2025
- PGNY Progyny, Inc: 1 buy, 5 sales, last May 23, 2024
- ATRA Atara Biotherapeutics, Inc: other filings, last May 31, 2023
- EPZM Epizyme, Inc: 1 sale, last Jun 30, 2019
- ARMO ARMO BioSciences, Inc: other filings, last Jun 22, 2018
- TSRO TESARO, Inc: 4 buys, last Jun 1, 2018
- BCRX Biocryst Pharmaceuticals Inc: other filings, last May 13, 2010